Readnour Robin Shane (CIK 1914883) reported 2 SEC Form 4 insider transactions across 1 companies over the past 18 months (most recent 2026-08-19). Recent activity: Sell ANTX (16,696 shares), Sell ANTX (18,706 shares). Source: SEC Form 4.
| Date | Company | Role | Type | Shares | Value |
|---|---|---|---|---|---|
| 2026-08-19 | AN2 Therapeutics, Inc. (ANTX) | Director | Sell | 16,696 | $100,313 |
| 2026-08-19 | AN2 Therapeutics, Inc. (ANTX) | Director | Sell | 18,706 | $112,389 |
Source: SEC Form 4 filings · as of 2026-08-19